Breaking News
Brady Bunch got measles and no one died
Chinese Concept Video Imagines the Future of Warfare
Massive Escalation: Iran Sends Large Ballistic Missile Salvo On Jordan Bases,...
Guns, Speech, and Government Power: Dexter Taylor Meets Ammon Bundy - Sept 8th, 8 pm EDT
Top Tech News
OPTIMUS CONFIRMED: 15,000 Bots This Year -- Tesla to $3,000
What is Going On With Robotaxi and Cybercab? Here Are All the Answers
Floating data center would provide water and electricity to 32,000 homes
OpenAI Cuts Off Elon's Cursor, Humanity's First Star Probe, and Trump's Nuclear Mars Shi
Eating pollution? Plastic-to-cookie technology raises safety, environmental concerns
Ford's $30,000 Fathom EV Truck Appears More Conventional Than Expected
Berlin-based artist Simon Weckert explored that idea with Digital Camouflage...
Tether expands tokenization business into Saudi Arabia, starting with real estate
Ukraine is facing a new problem in its war with Russia: 
It charges more than it discharges while driving 
AstraZeneca Coronavirus Vaccine to Be Pulled Worldwide for 'Commercial' Reasons
The Oxford-AstraZeneca coronavirus vaccine will be withdrawn worldwide just months after the firm admitted that the jab causes a rare but dangerous side effect, however, AstraZeneca insists that the decision to pull the vaccine was purely made for commercial reasons.
AstraZeneca pulled its "marketing authorisation" for its COVID-19 vaccine, known commercially as Vaxzevria, in the European Union on Tuesday and plans to do so in the UK and other countries where it was deployed in the coming months. The decision will not impact the United States, where the jab never received approval to go to market.
The pharmaceutical giant insisted that the decision was made for commercial considerations, saying that the vaccine is no longer being manufactured and that more recent vaccines have been developed to confront novel variants of the Chinese virus.